6th May 2005 16:15
AstraZeneca PLC06 May 2005 Dealing by Directors Companies Act 1985 Sections 324/329 We hereby inform you that, on 5 May 2005, Mr J R Symonds, a Director of theCompany, acquired 298 of the Company's USD0.25 Ordinary Shares at a price of£22.64 per share following the exercise of an option under the AstraZenecaSavings-Related Share Option Scheme. On 5 May 2005, Mr Symonds also purchased 300 of the Company's USD0.25 OrdinaryShares at a price of £23.64 per share using the proceeds of a savings accountlinked to an option under the AstraZeneca Savings-Related Share granted to himin 2001 at an option price of £29.71. This option will lapse on 1 June 2005 ifnot exercised before then. Mr Symonds' interest in the Ordinary Shares of the Company has increased to11,527 shares, which represents less than 0.001 per cent of the number of sharesin issue. Mr Symonds now has options over 312,753 Ordinary Shares. G H R MuskerCompany Secretary 6 May 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca